SKB BIO-B (06990) announced that on September 29, 2025, the company entered into a structured deposit agreement with Bank of China, pursuant to which the company agreed to subscribe to Bank of China structured deposits with a principal amount of RMB 440 million.

The announcement stated that considering the nature of the capital-guaranteed wealth management product with floating returns, the expected rate of return, and the medium-to-short-term nature of the wealth management product, using the group's idle proprietary funds to subscribe to Bank of China structured deposits will generate returns higher than those of general commercial bank deposits and will be beneficial to improving the efficiency of the group's idle fund utilization. The directors believe that the terms of the Bank of China structured deposits are fair and reasonable and are in the overall interests of the company's shareholders.